default author photo

Roberta Zappasodi

Memorial Sloan Kettering Cancer Center

New York, NY 10065

United States

SCHOLARLY PAPERS

1

DOWNLOADS

107

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Targeting Phosphatidylserine Enhances the Anti-Tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of Melanoma

Number of pages: 57 Posted: 03 Sep 2019
Memorial Sloan Kettering Cancer Center - Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, Parker Institute for Cancer Immunotherapy, Parker Institute for Cancer Immunotherapy, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Department of Medicine and Memorial Sloan Kettering Cancer Center - Department of Medicine
Downloads 107 (654,668)

Abstract:

Loading...

phosphatidylserine, radiation therapy, PD-1, melanoma, immunotherapy, immune modulation